U.S., U.K., and Canada have already approved the dispensation of Pfizer’s COVID-19 vaccine.
Also, check out our research on;
- COVID-19 Vaccine – Moderna; Timeline in U.S., U.K., E.U., China, Japan & Canada
- COVID-19 Vaccine – Novavax; Timeline in U.S., U.K., E.U., China, Japan & Canada
- COVID-19 Vaccine – Janssen; Timeline in U.S., U.K., E.U., China, Japan & Canada
- COVID-19 Vaccine – AstraZeneca; Timeline in U.S., U.K., E.U., China, Japan & Canada
- COVID-19 Vaccination Plans: Nebraska, Nevada, New Hampshire
- COVID-19 Vaccination Plans: New Jersey, New Mexico, New York
- COVID-19 Vaccination Plans: North Carolina, North Dakota, Ohio
- COVID-19 Vaccination Plans: Oklahoma, Oregon, Rhode Island
- COVID-19 Vaccination Plans: South Carolina, South Dakota, Tennessee
- COVID-19 Vaccination Plans: Texas, Utah, Vermont
- COVID-19 Vaccination Plans: Virginia, Washington, West Virginia
- COVID-19 Vaccination Plans: Wisconsin, Wyoming
- COVID-19 Vaccination Plans: Alabama, Alaska, Arizona
- COVID-19 Vaccination Plans: Arkansas, California, Colorado
- COVID-19 Vaccination Plans: Connecticut, Delaware, Florida
- COVID-19 Vaccination Plans: Georgia, Idaho, Illinois
- COVID-19 Vaccination Plans: Indiana, Iowa, Kansas
- COVID-19 Vaccination Plans: Kentucky, Louisiana, Maine
- COVID-19 Vaccination Plans: Maryland, Massachusetts, Michigan
- COVID-19 Vaccination Plans: Mississippi, Missouri, Montana
- COVID-19 Vaccine for African Americans
- U.S Vaccine Roll-Out Information
- How U.S. Federal and State Governments are Supporting Employees During the Coronavirus Pandemic
- The Use of Contact Tracing to Fight COVID-19
- Flu/Covid Testing Products
- On Friday, 11th of December 2020, the Food and Drug Administration (FDA) authorized the emergency use of Pfizer’s COVID-19 vaccine.
- According to the FDA, “the known and potential benefits of Pfizer-BioNTech COVID‑19 vaccine outweigh its potential risks for people ages 16 and older.”
- “Gen. Gustave Perna, chief operating officer of Operation Warp Speed,” projects, that the first vaccinations in US hospitals would begin on Monday, the 14th December 2020.
- According to Gen. Gustave Perna, boxes of Pfizer’s COVID-19 vaccine will be delivered through UPS and FedEx hubs, “to 636 predetermined locations nationwide.” 145 locations are expected to the Pfizer COVID‑19 on the 14th of December, while the others will receive the vaccine on the 15th, and 16th December.
- “An estimated 2.9 million doses will be distributed within the first week. That number is expected to ramp up significantly in the coming weeks, to as much as 40 million doses by the end of 2020.”
- On Wednesday, 9th December 2020, Health Canada approved the use of Pfizer’s COVID-19 vaccine.
- The first vaccinations are expected to begin in the 3rd week of December, and it is estimated that “every Canadian will be able to be inoculated” by the end of September 2021.
- “About 249,000 doses of the two-dose vaccine are expected to arrive by Dec. 31 and the first inoculations will be to residents and staff in long-term nursing homes.”
- Health Canada’s approval came after its “two months of review of the Pfizer clinical trials.”
- According to Health Canada, “the date provided supports favorably the efficacy of Pfizer-BioNTech COVID-19 vaccine as well as its safety.”
- 91-year-old Margaret Keenan was the first recipient of the Pfizer COVID-19 vaccine, she was vaccinated at 06:31 GMT, Tuesday, 8th of December.
- “The first 800,000 doses are going to people over 80 who are either hospitalized or already have outpatient appointments scheduled, along with nursing home workers.”
- 4 million vaccines are projected to be dispensed in the UK before the end of December 2020.
- On 2nd December 2020, the British regulators gave emergency authorization to use the Pfizer COVID-19 vaccine.
- The European Medicines Agency (EMA) has received an application for conditional marketing authorization (CMA) for BNT162b2, a COVID‑19 mRNA vaccine developed by BioNTech and Pfizer.
- “If EMA concludes that the benefits of the vaccine outweigh its risks in protecting against COVID‑19, it will recommend granting a conditional marketing authorization.”
- EMA will meet on 29th December 2020 to conclude its assessment of the Pfizer COVID-19 vaccine. “If approved, the vaccine could begin to be distributed before year’s end.“
- “European Commission President Ursula von der Leyen said Tuesday that the EU has secured around 2 billion doses of potential COVID-19 vaccine, according to The Associated Press. Deliveries to its 27 member nations will likely start before 2021.“
- “Pfizer began conducting a small-scale trial in Japan on Oct. 20. Its results, as well as those of the large-scale global test, are expected to lead the U.S. drugmaker to file for approval in Japan.”
- Starting early next year, Japan plans an orderly rollout of COVID-19 vaccines, that include thousands of freezers, “a reservation system and the repurposing of non-medical facilities as vaccination sites.”
- According to Satoshi Hori, professor of infectious disease control at Juntendo University in Tokyo, vaccines are expected to become available in Japan between March and May. Also, Japan plans to vaccinate its people before it hosts the Summer Olympics on July 23, 2021.
- “China, which is expected to approve mass production of locally developed vaccine candidates by the end of December, has pledged to share them with neighboring countries in a diplomatic charm offensive.”
- During an October visit to Cambodia, China Foreign Minister Wang Yi, said that Beijing will provide Chinese vaccines to the Southeast Asian countries on a priority basis.
Information surrounding when China is expected to receive Pfizer’s COVID-19 vaccine appears to be scarce in the public domain. We searched through media publications and industry reports among other credible sources to determine when Pfizer’s COVID-19 vaccine is expected in the US, Canada, the UK, the EU, Japan, and China, but the information was scarce on China, we believe this may be due to the fact that China intends to promote the production of its locally produced COVID-19 vaccines.